| Literature DB >> 21197467 |
Akane Tanaka1, Hiroshi Matsuda.
Abstract
Atopic dermatitis (AD) is the extremely complicated syndrome that various abnormalities develop in a heap. There are various factors in patients for the onset and exacerbation of AD, including genetic cofactors of individuals, environmental factors, the failure of the skin barrier function, unfavorable regulation of the immune system, and the hypersensitivity of sensory nerves. In recent years, there have been many trials of the drug discovery that targets itch, because itch is one of the most serious clinical symptoms of AD. The selection of the suitable animal model that represents the condition of patients, as well as innovative analyzing protocols that can precisely evaluate itch, is indispensable for investigation of an effective drug for AD. In the paper, the unique spontaneous animal model for AD (NC/NgaTnd mice) and the novel quantification system of the laboratory animals that may bring a great progress in the future study of itch are outlined.Entities:
Mesh:
Year: 2010 PMID: 21197467 PMCID: PMC3005841 DOI: 10.1155/2011/790436
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Figure 1NC/NgaTnd mice maintained in air-regulated SPF (a) or air-unregulated conventional circumstances (b).
Figure 2Generation of mast cell-deficient NC/NgaTnd mice. NC/NgaTnd mice with heterozygous (a) and homozygous (b) for the mast cell-deficient Wsh gene mutation.
Figure 3Microscopic features of skins obtained from NC/NgaTnd mice raised in SPF (a) or conventional (b) circumstances.
Figure 4A novel scratch analyzing system, SCLABA-Real. (a) The high-speed camera containing image processing system and the recording platform with a built-in near-infrared light panel for real-time quantification of scratching behavior of mice. (b) Real time record and analyze window. (c) Analyzed data of scratching frequency and duration. (d) Validation window for each frame.